139. Congenital cerebral hypomyelination Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 7 - (DrugBank : 2) / Drug target genes : 2 - Drug target pathways : 2
Congenital cerebral hypomyelination and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 139 | Congenital cerebral hypomyelination | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 2.000 |
| 19 | Lysosomal storage disease | 2.000 |
| 49 | Systemic lupus erythematosus | 2.000 |
| 222 | Primary nephrotic syndrome | 2.000 |
| 78 | Hypopituitarism | 2.000 |
| 210 | Single Ventricle | 2.000 |
| 80 | Resistance to thyroid hormone | 2.000 |
| 212 | Tricuspid atresia | 2.000 |